Trust Company of Oklahoma’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,053
| Closed | -$293K | – | 132 |
|
|
2024
Q2 | $293K | Sell |
2,053
-22
| -1% | -$2.92K | 0.1% | 117 |
|
|
2024
Q1 | $266K | Sell |
2,075
-400
| -16% | -$47.6K | 0.09% | 119 |
|
|
2023
Q4 | $256K | Sell |
2,475
-925
| -27% | -$91.5K | 0.1% | 126 |
|
|
2023
Q3 | $309K | Buy |
+3,400
| New | +$300K | 0.12% | 120 |
|
|
2023
Q1 | – | Sell |
-3,000
| Closed | -$203K | – | 144 |
|
|
2022
Q4 | $203K | Sell |
3,000
-1,500
| -33% | -$87.9K | 0.08% | 138 |
|
|
2022
Q3 | $224K | Sell |
4,500
-1,500
| -25% | -$80.4K | 0.11% | 106 |
|
|
2022
Q2 | $334K | Hold |
6,000
| – | – | 0.16% | 95 |
|
|
2022
Q1 | $333K | Hold |
6,000
| – | – | 0.13% | 104 |
|
|
2021
Q4 | $336K | Hold |
6,000
| – | – | 0.11% | 105 |
|
|
2021
Q3 | $288K | Sell |
6,000
-4,000
| -40% | -$193K | 0.1% | 112 |
|
|
2021
Q2 | $419K | Hold |
10,000
| – | – | 0.14% | 107 |
|
|
2021
Q1 | $337K | Hold |
10,000
| – | – | 0.12% | 111 |
|
|
2020
Q4 | $349K | Hold |
10,000
| – | – | 0.13% | 106 |
|
|
2020
Q3 | $347K | Buy |
+10,000
| New | +$333K | 0.14% | 99 |
|
|
2020
Q1 | $301K | Sell |
10,000
-1,394
| -12% | -$41.5K | 0.16% | 102 |
|
|
2019
Q4 | $330K | Buy |
11,394
+1,394
| +14% | +$38.6K | 0.13% | 111 |
|
|
2019
Q3 | $259K | Hold |
10,000
| – | – | 0.11% | 115 |
|
|
2019
Q2 | $255K | Hold |
10,000
| – | – | 0.11% | 119 |
|
|
2019
Q1 | $262K | Hold |
10,000
| – | – | 0.12% | 115 |
|
|
2018
Q4 | $230K | Hold |
10,000
| – | – | 0.12% | 115 |
|
|
2018
Q3 | $236K | Hold |
10,000
| – | – | 0.11% | 122 |
|
|
2018
Q2 | $231K | Hold |
10,000
| – | – | 0.11% | 119 |
|
|
2018
Q1 | $246K | Hold |
10,000
| – | – | 0.12% | 121 |
|
|
2017
Q4 | $268K | Hold |
10,000
| – | – | 0.13% | 110 |
|
|
2017
Q3 | $241K | Hold |
10,000
| – | – | 0.12% | 99 |
|
|
2017
Q2 | $214K | Buy |
+10,000
| New | +$202K | 0.11% | 100 |
|
|
2016
Q4 | – | Sell |
-10,000
| Closed | -$208K | – | 112 |
|
|
2016
Q3 | $208K | Hold |
10,000
| – | – | 0.11% | 103 |
|
|
2016
Q2 | $269K | Hold |
10,000
| – | – | 0.15% | 87 |
|
|
2016
Q1 | $271K | Sell |
10,000
-70
| -0.7% | -$1.88K | 0.15% | 88 |
|
|
2015
Q4 | $292K | Buy |
10,070
+70
| +0.7% | +$1.94K | 0.16% | 84 |
|
|
2015
Q3 | $271K | Hold |
10,000
| – | – | 0.16% | 86 |
|
|
2015
Q2 | $274K | Hold |
10,000
| – | – | 0.14% | 93 |
|
|
2015
Q1 | $267K | Buy |
+10,000
| New | +$230K | 0.13% | 93 |
|
Other funds holding NVO
F
Trust Company of Oklahoma's NVO Position: Q3 2024 in Review
Trust Company of Oklahoma sold out of Novo Nordisk (NVO) in Q3 2024, closing a stake of 2,053 shares — an estimated $293K sold.
Trust Company of Oklahoma first reported a position in NVO in Q1 2015 and held it in 33 quarters. The position peaked at $419K in Q2 2021. 1,785 funds tracked by Wall St. Rank hold NVO as of Q3 2024.
- Trust Company of Oklahoma reported no remaining Novo Nordisk position as of Q3 2024 after selling out during the quarter.
- Trust Company of Oklahoma sold 2,053 Novo Nordisk shares in Q3 2024, an estimated $293K.
- Trust Company of Oklahoma first reported a position in Novo Nordisk in Q1 2015 and held it in 33 quarters.
- Trust Company of Oklahoma's Novo Nordisk position peaked at $419K in Q2 2021.
- 1,785 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.
Based on Trust Company of Oklahoma's 13F filing for Q3 2024, filed 15 Oct 2024.